Stefan Härtle

459 total citations
12 papers, 368 citations indexed

About

Stefan Härtle is a scholar working on Immunology, Hematology and Organic Chemistry. According to data from OpenAlex, Stefan Härtle has authored 12 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Hematology and 3 papers in Organic Chemistry. Recurrent topics in Stefan Härtle's work include Multiple Myeloma Research and Treatments (4 papers), Toxin Mechanisms and Immunotoxins (4 papers) and Synthesis and Biological Evaluation (3 papers). Stefan Härtle is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Toxin Mechanisms and Immunotoxins (4 papers) and Synthesis and Biological Evaluation (3 papers). Stefan Härtle collaborates with scholars based in Germany, Austria and Belgium. Stefan Härtle's co-authors include Bernd Kaspers, Helmut Küchenhoff, Johannes Hirschberger, Nora Fenske, Katrin Hartmann, Stefan Steidl, Barbara Kohn, Hermine Agis, Hartmut Goldschmidt and Christian Peschel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Investigative Dermatology.

In The Last Decade

Stefan Härtle

12 papers receiving 362 citations

Peers

Countries citing papers authored by Stefan Härtle

Since Specialization

Citations

This map shows the geographic impact of Stefan Härtle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Härtle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Härtle more than expected).

Fields of papers citing papers by Stefan Härtle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Härtle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Härtle. The network helps show where Stefan Härtle may publish in the future.

Co-authorship network of co-authors of Stefan Härtle

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Härtle. A scholar is included among the top collaborators of Stefan Härtle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Härtle. Stefan Härtle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial 2022 ·Trials ·Katharina A. Mayer, Klemens Budde, Philip F. Halloran, Konstantin Doberer, Lionel Rostaing, Farsad Eskandary, (unknown), Markus Wahrmann, Heinz Regele, Sabine Schranz, Sarah Ely, Christa Firbas, Christian Schörgenhofer, Alexander Kainz, Alexandre Loupy, Stefan Härtle, Rainer Boxhammer, Bernd Jilma, Georg A. Böhmig	15
2	Phase 1 and 2 Randomized Clinical Studies Determine Lack of Efficacy for Anti-IL-17C Antibody MOR106 in Moderate–Severe Atopic Dermatitis 2022 ·Journal of Clinical Medicine ·Diamant Thaçi, Dave Singh, (unknown), (unknown), (unknown), Paul Passier, Susanne Rohrer, Johan Beetens, De Phung, (unknown), (unknown), (unknown), (unknown), Stefan Härtle, (unknown)	10
3	MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial 2020 ·The Lancet Haematology ·Marc S. Raab, Monika Engelhardt, Antje Blank, Hartmut Goldschmidt, Hermine Agis, Igor Wolfgang Blau, Hermann Einsele, Barbara Ferstl, Natalie Schub, Christoph Röllig, Katja Weisel, Mark Winderlich, (unknown), Stefan Härtle, Johannes Weirather, (unknown), Christian Peschel, Manik Chatterjee	68
4	Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis 2018 ·Journal of Investigative Dermatology ·N. Vandeghinste, (unknown), (unknown), (unknown), Florence Marsais, Jan D. Haas, Marielle Auberval, Felix Lauffer, Tara Moran, Maté Ongenaert, (unknown), Sonia Dupont, L. Lepescheux, Teresa García, Stefan Härtle, Kilian Eyerich, Padraic G. Fallon, Reginald Brys, Stefan Steidl	94
5	Tissue and time specific expression pattern of interferon regulated genes in the chicken 2017 ·BMC Genomics ·(unknown), Stefan Härtle, Thomas Lütteke, Bernd Kaspers, Sonja Härtle	17
6	Molecular basis of in vitro affinity maturation and functional evolution of a neutralizing anti-human GM-CSF antibody 2015 ·mAbs ·(unknown), Daniel Weinfurtner, Stefan Härtle, Ralf Strohner, Jark Böttcher, Martin Augustin, Ralf Ostendorp, Stefan Steidl	14
7	Phase I/IIa Study of the Human Anti-CD38 Antibody MOR202 (MOR03087) in Relapsed or Refractory Multiple Myeloma 2015 ·Blood ·Marc S. Raab, Manik Chatterjee, Hartmut Goldschmidt, Hermine Agis, (unknown), Hermann Einsele, (unknown), Barbara Ferstl, Martin Gramatzki, Christoph Röllig, Katja Weisel, (unknown), (unknown), Stefan Härtle, Christian Peschel	7
8	A phase I/IIa study of the human CD38 antibody MOR202 (MOR03087) in relapsed or refractory multiple myeloma 2015 ·Clinical Lymphoma Myeloma & Leukemia ·Marc S. Raab, Manik Chatterjee, Hartmut Goldschmidt, Hermine Agis, Igor‐Wolfgang Blau, H. Einsele, (unknown), Barbara Ferstl, Martin Gramatzki, Christoph Röllig, (unknown), (unknown), (unknown), Stefan Härtle, Christian Peschel	4
9	A phase I/IIa study of the human anti-CD38 antibody MOR202 (MOR03087) in relapsed or refractory multiple myeloma (rrMM). 2015 ·Journal of Clinical Oncology ·Marc S. Raab, Hartmut Goldschmidt, Hermine Agis, Igor Wolfgang Blau, Hermann Einsele, Monika Engelhardt, Barbara Ferstl, Martin Gramatzki, Christoph Röllig, Katja Weisel, (unknown), (unknown), Stefan Härtle, Christian Peschel	27
10	Cloning and expression of a truncated pigeon circovirus capsid protein suitable for antibody detection in infected pigeons 2009 ·Avian Pathology ·(unknown), Tim Finsterbusch, Stefan Härtle, Thomas Göbel, Annette Mankertz, Rüdiger Korbel, Christian Grund	25
11	Species-specific evolution of immune receptor tyrosine based activation motif-containing CEACAM1-related immune receptors in the dog 2007 ·BMC Evolutionary Biology ·Robert Kammerer, Tanja Popp, Stefan Härtle, Bernhard B. Singer, Wolfgang Zimmermann	28
12	Plasma interleukin‐6 response is predictive for severity and mortality in canine systemic inflammatory response syndrome and sepsis 2007 ·Veterinary Clinical Pathology ·(unknown), Barbara Kohn, (unknown), Nora Fenske, Helmut Küchenhoff, Katrin Hartmann, Stefan Härtle, Bernd Kaspers, Johannes Hirschberger	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact